{"id":473454,"date":"2021-04-08T06:33:28","date_gmt":"2021-04-08T10:33:28","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=473454"},"modified":"2021-04-08T06:33:28","modified_gmt":"2021-04-08T10:33:28","slug":"affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\/","title":{"rendered":"Affimed to Report Full Year 2020 Financial Results &amp;  Corporate Update on April 15, 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p>\n        <strong>Heidelberg, Germany, April 8, 2021<\/strong> \u2013 Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it will release full year 2020 results and corporate update on Thursday, April 15, 2021. The Company will host a conference call at 8:30 a.m. Eastern Daylight Time.<\/p>\n<p>The conference call will be available via phone and webcast. To access the call, please dial +1-646-741-3167 for U.S. callers, or +44 (0) 2071 928338 for international callers, and reference conference ID 4271307 approximately 15 minutes prior to the call.<\/p>\n<p>To access the live audio webcast of the conference call please visit the \u201cInvestors\u201d section of the company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XTsxj1F5YwvjSkHxe0nDC2Gqb0cr8F8GrKD2y9-RlLAz1FuUu97G9m0oYgAZ9oaTm6aexW7ERBzslwWrA6XISLKVEurNy1JmWzOhvdl50GRdJOGzU6xgx2D4NHbI0Ol91Z9DkIplj6AAtg6t0KR2QPfvOXG5K7LBlmfFpUFIkYU=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>https:\/\/www.affimed.com\/investors\/webcasts_cp\/<\/u><\/a>. A replay of the call will be archived on the Affimed website for 30 days after the call.<\/p>\n<p>\n        <strong>About Affimed N.V.<\/strong>\n      <\/p>\n<p>Affimed (Nasdaq: AFMD) is a clinical-stage immuno-oncology company committed to give patients back their innate ability to fight cancer by actualizing the untapped potential of the innate immune system. The company\u2019s proprietary ROCK\u00ae platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs. The ROCK\u00ae platform predictably generates customized innate cell engager (ICE\u00ae) molecules, which use patients\u2019 immune cells to destroy tumor cells. This innovative approach enabled Affimed to become the first company with a clinical-stage ICE\u00ae. Headquartered in Heidelberg, Germany, with offices in New York, NY, Affimed is led by an experienced team of biotechnology and pharmaceutical leaders united by a bold vision to stop cancer from ever derailing patients\u2019 lives. For more about the company\u2019s people, pipeline and partners, please visit: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=p-Z-E1BtgOS1vCiZYBcWfVg6x6G8XaHbMhoRhuwziV5V9mBuDsFfSX7dE13O7tTl0NCorjr-W5dqs2B74s8PEA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>www.affimed.com<\/u><\/a>. <\/p>\n<p>\n        <strong>Investor Relations Contact<\/strong>\n      <\/p>\n<p>Alex Fudukidis<br \/>Head of Investor Relations<br \/>E-Mail: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DYem8437D22U68ZIZp00yU2uUoB28Gisk3qRVdiIiX_xiuA6yg22WEXVHZbeUjE0WSImkp7dgIXOSlaz5TPTVznboDsMW5PK3oVzhbElZFo=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>a.fudukidis@affimed.com<\/u><\/a><br \/>Tel: +1 (917) 436-8102<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ3Njk4OCM0MDA5MDc1NTYjMjAwMzczNA==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml-eu.globenewswire.com\/release\/track\/3a7289cd-229f-45f2-afaf-b795f3eb7fb1\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Heidelberg, Germany, April 8, 2021 \u2013 Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it will release full year 2020 results and corporate update on Thursday, April 15, 2021. The Company will host a conference call at 8:30 a.m. Eastern Daylight Time. The conference call will be available via phone and webcast. To access the call, please dial +1-646-741-3167 for U.S. callers, or +44 (0) 2071 928338 for international callers, and reference conference ID 4271307 approximately 15 minutes prior to the call. To access the live audio webcast of the conference call please visit the \u201cInvestors\u201d section of the company\u2019s website at https:\/\/www.affimed.com\/investors\/webcasts_cp\/. A replay of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Affimed to Report Full Year 2020 Financial Results &amp;  Corporate Update on April 15, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-473454","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Affimed to Report Full Year 2020 Financial Results &amp; Corporate Update on April 15, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Affimed to Report Full Year 2020 Financial Results &amp; Corporate Update on April 15, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Heidelberg, Germany, April 8, 2021 \u2013 Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it will release full year 2020 results and corporate update on Thursday, April 15, 2021. The Company will host a conference call at 8:30 a.m. Eastern Daylight Time. The conference call will be available via phone and webcast. To access the call, please dial +1-646-741-3167 for U.S. callers, or +44 (0) 2071 928338 for international callers, and reference conference ID 4271307 approximately 15 minutes prior to the call. To access the live audio webcast of the conference call please visit the \u201cInvestors\u201d section of the company\u2019s website at https:\/\/www.affimed.com\/investors\/webcasts_cp\/. A replay of &hellip; Continue reading &quot;Affimed to Report Full Year 2020 Financial Results &amp; Corporate Update on April 15, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-08T10:33:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ3Njk4OCM0MDA5MDc1NTYjMjAwMzczNA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Affimed to Report Full Year 2020 Financial Results &amp; Corporate Update on April 15, 2021\",\"datePublished\":\"2021-04-08T10:33:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\\\/\"},\"wordCount\":311,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ3Njk4OCM0MDA5MDc1NTYjMjAwMzczNA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\\\/\",\"name\":\"Affimed to Report Full Year 2020 Financial Results &amp; Corporate Update on April 15, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ3Njk4OCM0MDA5MDc1NTYjMjAwMzczNA==\",\"datePublished\":\"2021-04-08T10:33:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ3Njk4OCM0MDA5MDc1NTYjMjAwMzczNA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ3Njk4OCM0MDA5MDc1NTYjMjAwMzczNA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Affimed to Report Full Year 2020 Financial Results &amp; Corporate Update on April 15, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Affimed to Report Full Year 2020 Financial Results &amp; Corporate Update on April 15, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\/","og_locale":"en_US","og_type":"article","og_title":"Affimed to Report Full Year 2020 Financial Results &amp; Corporate Update on April 15, 2021 - Market Newsdesk","og_description":"Heidelberg, Germany, April 8, 2021 \u2013 Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it will release full year 2020 results and corporate update on Thursday, April 15, 2021. The Company will host a conference call at 8:30 a.m. Eastern Daylight Time. The conference call will be available via phone and webcast. To access the call, please dial +1-646-741-3167 for U.S. callers, or +44 (0) 2071 928338 for international callers, and reference conference ID 4271307 approximately 15 minutes prior to the call. To access the live audio webcast of the conference call please visit the \u201cInvestors\u201d section of the company\u2019s website at https:\/\/www.affimed.com\/investors\/webcasts_cp\/. A replay of &hellip; Continue reading \"Affimed to Report Full Year 2020 Financial Results &amp; Corporate Update on April 15, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-08T10:33:28+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ3Njk4OCM0MDA5MDc1NTYjMjAwMzczNA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Affimed to Report Full Year 2020 Financial Results &amp; Corporate Update on April 15, 2021","datePublished":"2021-04-08T10:33:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\/"},"wordCount":311,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ3Njk4OCM0MDA5MDc1NTYjMjAwMzczNA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\/","name":"Affimed to Report Full Year 2020 Financial Results &amp; Corporate Update on April 15, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ3Njk4OCM0MDA5MDc1NTYjMjAwMzczNA==","datePublished":"2021-04-08T10:33:28+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ3Njk4OCM0MDA5MDc1NTYjMjAwMzczNA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ3Njk4OCM0MDA5MDc1NTYjMjAwMzczNA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-report-full-year-2020-financial-results-corporate-update-on-april-15-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Affimed to Report Full Year 2020 Financial Results &amp; Corporate Update on April 15, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/473454","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=473454"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/473454\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=473454"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=473454"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=473454"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}